Selvita shows 26% business growth in Q3 2016

Krakow, Poland – 23 November 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has published quarterly financial results showing outstanding business performance across all segments. Net sales revenues (excl. grants) rose from PLN 10.3 MM in Q3 2015 to PLN 17.7 MM in Q3 2016,…

More

Selvita exhibits at 34th Medicinal Chemistry Symposium in Japan

Kraków, Poland – 23 November 2016 – Selvita will participate and exhibit during the upcoming 34th Medicinal Chemistry Symposium, which will take place in Tsukuba, Japan, from November 30 to December 2, 2016. This symposium provides superb opportunities for participants to expand scientific knowledge and information on medicinal chemistry, and also to…

More

Selvita presents at Inv€$tival Showcase in London

Kraków, 03 November 2016 – Selvita will participate and present at the Biotech and Money Inv€$tival Showcase, taking place on November 18, in London, UK. Biotech and Money Inv€$tival Showcase, co-located with the Jefferies 2016 London Healthcare Conference in London, on November 18, showcases the latest investable public and private life…

More

Selvita presents at BIO-Europe 2016

Kraków, 26 October 2016 – Selvita will participate and present at the upcoming BIO-Europe 2016 conference, which is to take place on November 7-9, 2016, in Cologne, Germany. Selvita will be presenting in the Oncology category.  The presentation will be held by Ms. Magdalena Marciniak, Business Alliance Manager at Selvita, on November 9, at…

More

Selvita presents at Drug Discovery Congress USA

San Diego, US – 03 October 2016 – Selvita is a proud sponsor of the Drug Discovery Congress USA, starting today, October 03, in San Diego, CA. The event is taking place at Hilton San Diego Mission Valley from 03 -04 October 2016, and offers a perfect mix of custom-tailored partnering…

More

...89101112...